Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-20

Clinical Trial Update: Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?

View source ↗

Summary

A completed Vanderbilt University-sponsored clinical trial explored predictive approaches for identifying individuals with gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University | Conditions: Gastroesophageal Reflux Disease | Status: COMPLETED